FIELD: medicine.
SUBSTANCE: invention concerns restoration of sensitivity of thrombocytes to agonists, i.e. to aggregation inductors at a metabolic syndrome (MS). For this purpose within 3 months carry out the complex therapy including individually picked up hypohigh-calorie diet, the dosed out physical trainings, and also administration of diltiazem on 90 mg 2 times a day and perindopril on 4 mg of 1 times a day in the morning.
EFFECT: decrease of risk of a thrombogenesis at patients metabolic syndrome at the expense of normalisation of sensitivity of thrombocytes to aggregation inductors.
1 ex, 3 dwg, 2 tbl
